Obstructive Sleep ApneaMRA PORCNCT07305168
A Multicenter Retrospective Analysis of Postoperative Respiratory Complications in Children With Obstructive Sleepapnea
An observational study of Obstructive Sleep Apnea and Postoperative Respiratory Complications, run by University Hospital, Antwerp at 2 sites in 2 countries.
Trial summary
This retrospective observational study aims to evaluate postoperative respiratory complications (PORC) after (adeno)tonsillectomy in children with OSA. In order to increase the number of patients available for analysis, we will merge data collected at UZA with data collected at the the Department of Sleep Laboratory… Read more about this study
- Who is it for?
- Ages 1 year to 18 years
- Conditions the study is for
- Obstructive Sleep Apnea, Postoperative Respiratory Complications, Adenotonsillectomy
- How many people
- 200 participants
- Where
- 2 sitesin 2 countries
- Study dates
- 2 May 2022to 1 Mar 2027
- Phase
- Observational
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 1 year to 18 years
- All sexes
- No healthy volunteers
- Child, Adult
Study population: children with or without co-morbidities undergoing (adeno)tonsillectomy for OSAS during time frame of the study period
Who may be able to join
- scheduled for (adeno)tonsillectomy as treatment for OSAS
Who cannot join
- other surgery than (adeno)tonsillectomy performed as treatment for OSAS
- Polysomnography not available within 1 year before surgery
Trial locations and contacts
2 sites in 2 countries. Contact the study team or a site near you to ask about taking part.
2 sites in 2 countries
Belgium1 site, 1 recruiting
- Recruiting
Antwerp University Hospital
Edegem, Antwerp, 2650
Vera Saldien, MD, PhD, 38214788 ext. 0032, vera.saldien@uza.be
Joke De Wachter, 38213042 ext. 0032, joke.dewachter@uza.be
About this study
This retrospective observational study aims to evaluate postoperative respiratory complications (PORC) after (adeno)tonsillectomy in children with OSA.
In order to increase the number of patients available for analysis, we will merge data collected at UZA with data collected at the the Department of Sleep Laboratory and Sleep Surgery at the Heim Pal National Pediatric Institute, Hungary. These colleagues performed an identical prospective data collection.
Read the detailed description
This is a retrospective, multicenter cohort study using anonymized electronic health record data collected in a prospective study (PORC -EDGE 2364) performed at UZA and an identical prospective data collection performed by collegues at Department of Sleep Laboratory and Sleep surgery at Heim Pal National Pediatric Institute at Budapest.Data are collected from otherwise healthy children and children with varying comorbidities undergoing (adeno)-tonsillecty for Obstructive Sleepapnea (OSAS). Per-postoperative management was carried out according to a predefined treatment protocol.
As this study uses existing data, no informed consent was required. The aim of the current project is to answer the following questions.
- What is the prevalence of Postoperative Respiratory Complications (PORC) in children undergoing surgical treatment for OSA and is the prevalence different according to the underlying comorbid condition (i.e obesity, craniofacial malformation, syndromes Down syndrome, neurological conditions affecting upper airway muscle tone)?
- Which factors are associated with the occurrence of PORC (Polysomnogram (PSG) related factors such as obstructive Apnea-Hypopnea Index (oAHI), minimum oxygen saturation during PSG, and patient related factors such as age at time of surgery, presence of a comorbidity)?
- Is it possible to develop a management algorithm for postoperative management based upon the risk factors for PORC above.
- Conditions
- Obstructive Sleep Apnea, Postoperative Respiratory Complications, Adenotonsillectomy, Child Obesity, Craniofacial Abnormalities, Children With Down Syndrome
- Medical subject headings
- Sleep Apnea, Obstructive, Pediatric Obesity, Craniofacial Abnormalities, Nervous System Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Children with Obstructive Sleepapnea (OSA) | Children with OSA after (adeno)tonsillectomy |
What is being measured
The primary outcome is the main question the study is designed to answer.
What is the prevalence of PORC in children undergoing surgical treatment for OSA and is the prevalence different according to the underlying comorbid condition
Number of PORC
Measured: 24 hours postoperative
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Dec 2025
- Study start2 May 2022
- Primary completion30 Dec 2025 (estimated)
- Study completion1 Mar 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Obstructive Sleep ApneaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 200 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University Hospital, Antwerp
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Vera Saldien, University Hospital, Antwerp
- Investigators
- Vera Saldien, MD, Principal investigator, University Hospital, Antwerp
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07305168
- Sponsor's protocol ID
- EDGE 004218
- Acronym
- MRA PORC
- Status last verified
- Dec 2025
- First submitted
- 17 Nov 2025
- Last updated
- 26 Dec 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No